These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9761975)

  • 1. The use of mycophenolate mofetil (Cellcept) in renal transplantation.
    Vanrenterghem Y
    Contrib Nephrol; 1998; 124():64-9; discussion 69-75. PubMed ID: 9761975
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term dosing patterns of enteric-coated mycophenolate sodium or mycophenolate mofetil with tacrolimus after renal transplantation.
    Langone A; Shihab F; Pankewycz O; Doria C; Wiland A; McCague K; Chan L
    Clin Transplant; 2014 Sep; 28(9):961-7. PubMed ID: 24893821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy.
    Schwarz C; Regele H; Huttary N; Wahrmann M; Exner M; Nagy-Bojarsky K; Kletzmayr J; Hörl WH; Böhmig GA
    Wien Klin Wochenschr; 2006 Jul; 118(13-14):397-404. PubMed ID: 16865644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of mycophenolate mofetil in immunosuppressive protocols in elderly renal transplant recipients.
    Sureshkumar KK; Nghiem DD
    Transplantation; 2003 Jul; 76(2):441-2. PubMed ID: 12883215
    [No Abstract]   [Full Text] [Related]  

  • 5. [Initial experience with mycophenolate mofetil (RS 61443) after kidney transplantation].
    Friedrich J; Erhard J
    Zentralbl Chir; 1994; 119(1):48-9. PubMed ID: 8147160
    [No Abstract]   [Full Text] [Related]  

  • 6. Economic impact and long-term graft outcomes of mycophenolate mofetil dosage modifications following gastrointestinal complications in renal transplant recipients.
    Machnicki G; Ricci JF; Brennan DC; Schnitzler MA
    Pharmacoeconomics; 2008; 26(11):951-67. PubMed ID: 18850764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mycophenolate mofetil in renal transplantation].
    Uchida K
    Nihon Rinsho; 2005 May; 63 Suppl 5():684-91. PubMed ID: 15954430
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunosuppressive drug monitoring of cyclosporine, tacrolimus, and mycophenolate mofetil in renal transplantation].
    Uchida K
    Nihon Jinzo Gakkai Shi; 2005; 47(4):423-9. PubMed ID: 15971884
    [No Abstract]   [Full Text] [Related]  

  • 9. Generic formulation of mycophenolate mofetil (Myfenax) in de novo renal transplant recipients: results of 12-month observation.
    Rutkowski B; Bzoma B; Dębska-Ślizień A; Chamienia A
    Transplant Proc; 2014 Oct; 46(8):2683-8. PubMed ID: 25380894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear benefit of mycophenolate mofetil-based triple therapy in reducing the incidence of acute rejection after living donor renal transplantations.
    Kim YS; Moon JI; Kim SI; Park K
    Transplantation; 1999 Aug; 68(4):578-81. PubMed ID: 10480420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil-based immunosuppressive minimization and withdrawal strategies in renal transplantation: possible risks and benefits.
    Meier-Kriesche HU
    Curr Opin Nephrol Hypertens; 2006 Jun; 15 Suppl 1():S1-5. PubMed ID: 16829733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation.
    Bruce DS; Woodle ES; Newell KA; Millis JM; Cronin DC; Loss GE; Pellar S; Josephson MA; Thistlethwaite JR
    Transplant Proc; 1998 Mar; 30(2):507-8. PubMed ID: 9532150
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of mycophenolate mofetil and azathioprine dose on renal allograft outcome in the United kingdom.
    Shah S; Collett D; Johnson R; Raftery M; Rudge C; Yaqoob MM
    Transplantation; 2008 Oct; 86(8):1035-42. PubMed ID: 18946340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic window of mycophenolate mofetil for preventing acute graft rejection following renal transplantation].
    Yu L; Zhou M; Luo M
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Dec; 34(12):1842-5. PubMed ID: 25537916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Prospective Randomized, Comparative Trial of High-Dose Mizoribine Versus Mycophenolate Mofetil in Combination With Tacrolimus and Basiliximab for Living Donor Renal Transplant: A Multicenter Trial.
    Ishida H; Takahara S; Amada N; Tomikawa S; Chikaraishi T; Takahashi K; Uchida K; Akiyama T; Tanabe K; Toma H;
    Exp Clin Transplant; 2016 Oct; 14(5):518-525. PubMed ID: 27733107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil (Cellcept) in renal transplantation: the European experience. The European Mycophenolate Mofetil Co-operative Study Group.
    Carl S; Wiesel M
    Transplant Proc; 1997 Nov; 29(7):2932-5. PubMed ID: 9365619
    [No Abstract]   [Full Text] [Related]  

  • 17. First results with a quadruple therapy regimen including tacrolimus and mycophenolate mofetil in patients after combined pancreas and kidney transplantation.
    Kahl A; Bechstein WO; Platz K; Müller A; Berweck S; Venz S; Neuhaus P; Frei U
    Transplant Proc; 1998 Mar; 30(2):505-6. PubMed ID: 9532149
    [No Abstract]   [Full Text] [Related]  

  • 18. Trough blood concentrations in long-term treatment with mycophenolate mofetil.
    Sanquer S; Breil M; Baron C; Dahmane D; Astier A; Lang P
    Lancet; 1998 May; 351(9115):1557. PubMed ID: 10326544
    [No Abstract]   [Full Text] [Related]  

  • 19. [The value of mycophenolate mofetil in kidney transplantation. Joint Symposium of the Dutch Society of Nephrology, the German Society of Nephrology and the German Working Group for Clinical Nephrology. Aachen, 8 September 1997].
    Dtsch Med Wochenschr; 1997 Nov; 122(47 Suppl):1-6. PubMed ID: 9431325
    [No Abstract]   [Full Text] [Related]  

  • 20. Prophylactic effect of mycophenolate mofetil on early outcomes of living donor kidney transplantation.
    Samadzadeh B; Alemi M; Heidarnejadiyan J; Torkamanasadi F
    Iran J Kidney Dis; 2012 Jan; 6(1):63-8. PubMed ID: 22218122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.